Immunological evidence for functional rather than structural mimicry by a Shigella flexneri Y polysaccharide-mimetic peptide

Clinical and Vaccine Immunology

Volumn 15, Issue 7, 2008, Pages 1106-1114

  Borrelli, Silvia ^a   Hossany, Rehana B ^a   Pinto, B Mario ^a  

^a SIMON FRASER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; BACTERIAL POLYSACCHARIDE; BOVINE SERUM ALBUMIN; CARBOHYDRATE; CARRIER PROTEIN; IMMUNOGLOBULIN G; METHIONYLASPARTYLTRYPTOPHYLASPARAGINYLMETHIONYLHISTIDYLALANYLALANINE; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; TETANUS TOXOID;

ADOLESCENT; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIBODY TITER; ANTIGEN BINDING; ARTICLE; BAGG ALBINO MOUSE; CONTROLLED STUDY; CROSS REACTION; DRUG DESIGN; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNE RESPONSE; IMMUNOGENICITY; MOLECULAR MIMICRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; SEROTYPE; SHIGELLA FLEXNERI; X RAY CRYSTALLOGRAPHY;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODIES, MONOCLONAL; CROSS REACTIONS; FEMALE; MICE; MICE, INBRED BALB C; MOLECULAR MIMICRY; POLYSACCHARIDES, BACTERIAL; PROTEOGLYCANS; SHIGELLA FLEXNERI;

EID: 47649086659     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00050-08     Document Type: Article

References (39)

1. Altman, E., and D. R. Bundle. 1994. Polysaccharide affinity columns for purification of lipopolysaccharide-specific murine monoclonal antibodies. Methods Enzymol. 247:243-253.
2. Beenhouwer, D. O., R. J. May, P. Valadon, and M. D. Scharff. 2002. High affinity mimotope of the polysaccharide capsule of Cryptococcus neoformans identified from an evolutionary phage peptide library. J. Immunol. 169:6992-6999.
3. Belot, F., C. Guerreiro, F. Baleux, and L. A. Mulard. 2005. Synthesis of two linear PADRE conjugates bearing a deca- or pentadecasaccharide B epitope as potential synthetic vaccines against Shigella flexneri serotype 2a infection. Chem. Eur. J. 11:1625-1635.
4. Bock, K., S. Josephson, and D. R. Bundle. 1982. Lipopolysaccharide solution conformation: antigen shape inferred from high-resolution H-1 and C-13 nuclear magnetic-resonance spectroscopy and hard-sphere calculations. J. Chem. Soc. Perkin Trans. 2:59-70.
5. Bonferroni, C. E. 1935. Il calcolo delle assicurazioni su gruppi di teste, p. 13-60. In Studi in onore del professore Salvatore Ortu Carboni. Casa Editrice Milani, Rome, Italy.
6. Borrelli, S., R. B. Hossany, S. Findlay, and B. M. Pinto. 2006. Immunological evidence for peptide-carbohydrate mimicry with a group A Streptococcus polysaccharide-mimetic peptide. Am. J. Immunol. 2:73-83.
7. Bundle, D. R. 1989. Antibody combing sites and oligosaccharide determinants studied by competitive binding, sequencing and X-ray crystallography. Pure Appl. Chem. 61:1171-1180.
8. Carlin, N. I., M. A. Gidney, A. A. Lindberg, and D. R. Bundle. 1986. Characterization of Shigella flexneri-specific murine monoclonal antibodies by chemically defined glycoconjugates. J. Immunol. 137:2361-2366.
9. Carlin, N. I., A. A. Lindberg, K. Bock, and D. R. Bundle. 1984. The Shigella flexneri O-antigenic polysaccharide chain. Nature of the biological repeating unit. Eur. J. Biochem. 139:189-194.
10. Chowers, Y., J. Kirschner, N. Keller, I. Barshack, S. Bar-Meir, S. Ashkenazi, R. Schneerson, J. Robbins, and J. H. Passwell. 2007. Specific polysaccharide conjugate vaccine-induced IgG antibodies prevent invasion of Shigella into Caco-2 cells and may be curative. Proc. Natl. Acad. Sci. USA 104:2396-2401.
11. Clement, M. J., A. Fortune, A. Phalipon, V. Marcel-Peyre, C. Simenel, A. Imberty, M. Delepierre, and L. A. Mulard. 2006. Toward a better understanding of the basis of the molecular mimicry of polysaccharide antigens by peptides: the example of Shigella flexneri 5A. J. Biol. Chem. 281:2317-2332.
12. Craig, L., P. C. Sanschagrin, A. Rozek, S. Lackie, L. A. Kuhn, and J. K. Scott. 1998. The role of structure in antibody cross-reactivity between peptides and folded proteins. J. Mol. Biol. 281:183-201.
13. Dyson, H. J., M. Rance, R. A. Houghten, P. E. Wright, and R. A. Lerner. 1988. Folding immunogenic peptide fragments of proteins in water solution. II. The nascent helix. J. Mol. Biol. 201:201-217.
14. Fleuridor, R., A. Lees, and L. A. Pirofski. 2001. A cryptococcal capsular polysaccharide mimotope prolongs the survival of mice with Cryptococcus neoformans infection. J. Immunol. 166:1087-1096.
15. Harris, S. L., L. Craig, J. S. Mehroke, M. Rashed, M. B. Zwick, K. Kenar, E. J. Toone, N. Greenspan, F. I. Auzanneau, J. R. Marino-Albernas, B. M. Pinto, and J. K. Scott. 1997. Exploring the basis of peptide-carbohydrate cross-reactivity: evidence for discrimination by peptides between closely related anti-carbohydrate antibodies. Proc. Natl. Acad. Sci. USA 94:2454-2459.
16. Hossany, R. B., M. A. Johnson, A. A. Eniade, and B. M. Pinto. 2004. Synthesis and immunochemical characterization of protein conjugates of carbohydrate and carbohydrate-mimetic peptides as experimental vaccines. Bioorg. Med. Chem. 12:3743-3754.
17. Johnson, M. A., A. A. Eniade, and B. M. Pinto. 2003. Rational design and synthesis of peptide ligands for an anti-carbohydrate antibody and their immunochemical characterization. Bioorg. Med. Chem. 11:781-788.
18. Johnson, M. A., M. Jaseja, W. Zou, H. J. Jennings, V. Copie, B. M. Pinto, and S. H. Pincus. 2003. NMR studies of carbohydrates and carbohydrate-mimetic peptides recognized by an anti-group B Streptococcus antibody. J. Biol. Chem. 278:24740-24752.
19. Johnson, M. A., and B. M. Pinto. Bioactive conformations II. Top. Curr. Chem., in press.
20. Johnson, M. A., and B. M. Pinto. 2002. Molecular mimicry of carbohydrates by peptides. Aust. J. Chem. 55:13-25.
21. Johnson, M. A., and B. M. Pinto. 2004. NMR spectroscopic and molecular modeling studies of protein-carbohydrate and protein-peptide interactions. Carbohydr. Res. 339:907-928.
22. Johnson, M. A., A. Rotondo, and B. M. Pinto. 2002. NMR studies of the antibody-bound conformation of a carbohydrate-mimetic peptide. Biochemistry 41:2149-2157.
23. Kotloff, K. L., J. P. Winickoff, B. Invanoff, J. D. Clemens, D. L. Swerdlow, and P. J. Sansonetti. 1999. Global burden of Shigella infections: implications for vaccine development and implementation of control strategies. Bull. W. H. O. 77:651-665.
24. Luijkx, T., H. van Dijken, C. van Els, and G. van den Dobbelsteen. 2006. Heterologous prime-boost strategy to overcome weak immunogenicity of two serosubtypes in hexavalent Neisseria meningitidis outer membrane vesicle vaccine. Vaccine 24:1569-1577.
25. Maitta, R. W., K. Datta, A. Lees, S. S. Belouski, and L. A. Pirofski. 2004. Immunogenicity and efficacy of Cryptococcus neoformans capsular polysaccharide glucuronoxylomannan peptide mimotope-protein conjugates in human immunoglobulin transgenic mice. Infect. Immun. 72:196-208.
26. Mann, H. B., and D. R. Whitney. 1947. On a test of whether one of two random variables is stochastically larger than the other. Ann. Math. Stat. 18:50-60.
27. Moe, G. R., P. Zuno-Mitchell, S. N. Hammond, and D. M. Granoff. 2002. Sequential immunization with vesicles prepared from heterologous Neisseria meningitidis strains elicits broadly protective serum antibodies to group B strains. Infect. Immun. 70:6021-6031.
28. Monzavi-Karbassi, B., G. Cunto-Amesty, P. Luo, and T. Kieber-Emmons. 2002. Peptide mimotopes as surrogate antigens of carbohydrates in vaccine discovery. Trends Biotechnol. 20:207-214.
29. Phalipon, A., C. Costachel, C. Grandjean, A. Thuizat, C. Guerreiro, M. Tanguy, F. Nato, B. V. L. Normand, F. Belot, K. Wright, V. Marcel-Peyre, P. J. Sansonetti, and L. A. Mulard. 2006. Characterization of functional oligosaccharide mimics of the Shigella flexneri serotype 2a O-antigen: implications for the development of a chemically defined glycoconjugate vaccine. J. Immunol. 176:1686-1694.
30. Pinto, B. M., D. G. Morissette, and D. R. Bundle. 1987. Synthesis of oligosaccharides corresponding to biological repeating units of Shigella flexneri variant Y polysaccharide. 1. Overall strategy, synthesis of a key trisaccharide intermediate, and synthesis of a pentasaccharide. J. Chem. Soc. Perkin Trans. 1:9-14.
31. Pinto, B. M., K. B. Reimer, D. G. Morissette, and D. R. Bundle. 1989. Oligosaccharides corresponding to biological repeating units of Shigella flexneri variant-Y polysaccharide. 2. Synthesis and two-dimensional NMR analysis of a hexasaccharide hapten. J. Org. Chem. 54:2650-2656.
32. Pinto, B. M., K. B. Reimer, D. G. Morissette, and D. R. Bundle. 1990. Synthesis and 2D-NMR analysis of a pentasaccharide glycoside of the biological repeating units of Shigella flexneri variant-Y polysaccharide and the preparation of a synthetic antigen. Carbohydr. Res. 196:156-166.
33. Vyas, M. N., N. K. Vyas, P. J. Meikle, B. Sinnott, B. M. Pinto, D. R. Bundle, and F. A. Quiocho. 1993. Preliminary crystallographic analysis of a Fab specific for the O-antigen of Shigella flexneri cell-surface lipopolysaccharide with and without bound saccharides. J. Mol. Biol. 231:133-136.
34. Vyas, N. K., M. N. Vyas, M. C. Chervenak, D. R. Bundle, B. M. Pinto, and F. A. Quiocho. 2003. Structural basis of peptide-carbohydrate mimicry in an antibody-combining site. Proc. Natl. Acad. Sci. USA 100:15023-15028.
35. Vyas, N. K., M. N. Vyas, M. C. Chervenak, M. A. Johnson, B. M. Pinto, D. R. Bundle, and F. A. Quiocho. 2002. Molecular recognition of oligosaccharide epitopes by a monoclonal Fab specific for Shigella flexneri Y lipopolysaccharide: X-ray structures and thermodynamics. Biochemistry 41:13575-13586.
36. Wilcoxon, F. 1945. Individual comparisons by ranking methods. Biometrics 1:80-83.
37. Woodland, D. L. 2004. Jump-starting the immune system: prime-boosting comes of age. Trends Immunol. 25:98-104.
38. Wright, K., C. Guerreiro, I. Laurent, F. Baleux, and L. A. Mulard. 2004. Preparation of synthetic glycoconjugates as potential vaccines against Shigella flexneri serotype 2a disease. Org. Biomol. Chem. 2:1518-1527.
39. Zou, W., S. Borrelli, M. Gilbert, T. Liu, R. A. Pon, and H. J. Jennings. 2004. Bioengineering of surface GD3 ganglioside for immunotargeting human melanoma cells. J. Biol. Chem. 279:25390-25399.